Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells

The development of environment-friendly new Poly-adenosine diphosphate (ADP)-ribose Polymerase (PARP) inhibitors are highly essential because of their involvement in the survival of cancer cells. Therefore, a library of indazolyl-substituted-1,3,4-oxadiazoles known to inhibit PARP in cancer cells wa...

Full description

Bibliographic Details
Main Authors: Sindhu M. Parameshwaraiah, Zhang Xi, Akshay Ravish, Arunkumar Mohan, Vanishree Shankarnaik, Dukanya Dukanya, Shreeja Basappa, Habbanakuppe D. Preetham, Ganga Periyasamy, Santhosh L. Gaonkar, Peter E. Lobie, Vijay Pandey, Basappa Basappa
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Catalysts
Subjects:
Online Access:https://www.mdpi.com/2073-4344/13/8/1185
_version_ 1797585172494811136
author Sindhu M. Parameshwaraiah
Zhang Xi
Akshay Ravish
Arunkumar Mohan
Vanishree Shankarnaik
Dukanya Dukanya
Shreeja Basappa
Habbanakuppe D. Preetham
Ganga Periyasamy
Santhosh L. Gaonkar
Peter E. Lobie
Vijay Pandey
Basappa Basappa
author_facet Sindhu M. Parameshwaraiah
Zhang Xi
Akshay Ravish
Arunkumar Mohan
Vanishree Shankarnaik
Dukanya Dukanya
Shreeja Basappa
Habbanakuppe D. Preetham
Ganga Periyasamy
Santhosh L. Gaonkar
Peter E. Lobie
Vijay Pandey
Basappa Basappa
author_sort Sindhu M. Parameshwaraiah
collection DOAJ
description The development of environment-friendly new Poly-adenosine diphosphate (ADP)-ribose Polymerase (PARP) inhibitors are highly essential because of their involvement in the survival of cancer cells. Therefore, a library of indazolyl-substituted-1,3,4-oxadiazoles known to inhibit PARP in cancer cells was synthesized by a green protocol. Furthermore, the cytotoxic effects of these compounds were evaluated in human MCF-7 breast cancer (BC) cells, which revealed that the compound 2-(3-bromo-4-nitrophenyl)-5-(1-methyl-1<i>H</i>-indazol-3-yl)-1,3,4-oxadiazole (<b>8</b>) inhibited viability with an IC<sub>50</sub> value of 1.57 µM. Since the oxadiazole structure was extensively used in medicinal chemistry applications, the reported environment-friendly protocol was superior to the conventional method. Further, computational mechanistic studies revealed that the oxadiazole ring formation occurred spontaneously when compared to the conventional method. Additionally, the in silico bioinformatic studies of oxadiazole binding towards PARP1 showed that compound <b>8</b> could bind to PARP1 with higher binding energy (BE) of −7.29 kcal/mol when compound to compound 5s (BE = −7.17 kcal/mol), a known PARP cleavage oxadiazole structure (2-(3,4-Dimethoxybenzyl)-5-(3-(2-fluoro-3-methylpyridin-4-yl)phenyl)-1,3,4-oxadiazole) indicative of the improvement in the optimization process. In conclusion, a newer indazolyl-oxadiazole compound is reported, which could serve as a lead in developing PARP inhibitors in BC cells.
first_indexed 2024-03-11T00:03:13Z
format Article
id doaj.art-4d8a33622ab94a81bc816b19cb72f935
institution Directory Open Access Journal
issn 2073-4344
language English
last_indexed 2024-03-11T00:03:13Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Catalysts
spelling doaj.art-4d8a33622ab94a81bc816b19cb72f9352023-11-19T00:35:24ZengMDPI AGCatalysts2073-43442023-08-01138118510.3390/catal13081185Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer CellsSindhu M. Parameshwaraiah0Zhang Xi1Akshay Ravish2Arunkumar Mohan3Vanishree Shankarnaik4Dukanya Dukanya5Shreeja Basappa6Habbanakuppe D. Preetham7Ganga Periyasamy8Santhosh L. Gaonkar9Peter E. Lobie10Vijay Pandey11Basappa Basappa12Laboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysore 570006, IndiaShenzhen Bay Laboratory, Shenzhen 518055, ChinaLaboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysore 570006, IndiaLaboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysore 570006, IndiaDepartment of Chemistry, Central College Campus, Bangalore University, Bangalore 560001, IndiaLaboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysore 570006, IndiaDepartment of Chemistry, BITS-Pilani Hyderabad Campus, Jawahar Nagar, Medchal, Hyderabad 500078, IndiaLaboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysore 570006, IndiaDepartment of Chemistry, Central College Campus, Bangalore University, Bangalore 560001, IndiaDepartment of Chemistry, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal 576104, IndiaShenzhen Bay Laboratory, Shenzhen 518055, ChinaTsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaLaboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysore 570006, IndiaThe development of environment-friendly new Poly-adenosine diphosphate (ADP)-ribose Polymerase (PARP) inhibitors are highly essential because of their involvement in the survival of cancer cells. Therefore, a library of indazolyl-substituted-1,3,4-oxadiazoles known to inhibit PARP in cancer cells was synthesized by a green protocol. Furthermore, the cytotoxic effects of these compounds were evaluated in human MCF-7 breast cancer (BC) cells, which revealed that the compound 2-(3-bromo-4-nitrophenyl)-5-(1-methyl-1<i>H</i>-indazol-3-yl)-1,3,4-oxadiazole (<b>8</b>) inhibited viability with an IC<sub>50</sub> value of 1.57 µM. Since the oxadiazole structure was extensively used in medicinal chemistry applications, the reported environment-friendly protocol was superior to the conventional method. Further, computational mechanistic studies revealed that the oxadiazole ring formation occurred spontaneously when compared to the conventional method. Additionally, the in silico bioinformatic studies of oxadiazole binding towards PARP1 showed that compound <b>8</b> could bind to PARP1 with higher binding energy (BE) of −7.29 kcal/mol when compound to compound 5s (BE = −7.17 kcal/mol), a known PARP cleavage oxadiazole structure (2-(3,4-Dimethoxybenzyl)-5-(3-(2-fluoro-3-methylpyridin-4-yl)phenyl)-1,3,4-oxadiazole) indicative of the improvement in the optimization process. In conclusion, a newer indazolyl-oxadiazole compound is reported, which could serve as a lead in developing PARP inhibitors in BC cells.https://www.mdpi.com/2073-4344/13/8/11851,3,4-oxadiazolespoly(ADP-ribose) polymerasehuman breast cancerauto dockdensity function theory
spellingShingle Sindhu M. Parameshwaraiah
Zhang Xi
Akshay Ravish
Arunkumar Mohan
Vanishree Shankarnaik
Dukanya Dukanya
Shreeja Basappa
Habbanakuppe D. Preetham
Ganga Periyasamy
Santhosh L. Gaonkar
Peter E. Lobie
Vijay Pandey
Basappa Basappa
Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells
Catalysts
1,3,4-oxadiazoles
poly(ADP-ribose) polymerase
human breast cancer
auto dock
density function theory
title Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells
title_full Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells
title_fullStr Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells
title_full_unstemmed Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells
title_short Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells
title_sort development of an environment friendly and electrochemical method for the synthesis of an oxadiazole drug scaffold that targets poly adp ribose polymerase in human breast cancer cells
topic 1,3,4-oxadiazoles
poly(ADP-ribose) polymerase
human breast cancer
auto dock
density function theory
url https://www.mdpi.com/2073-4344/13/8/1185
work_keys_str_mv AT sindhumparameshwaraiah developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT zhangxi developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT akshayravish developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT arunkumarmohan developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT vanishreeshankarnaik developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT dukanyadukanya developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT shreejabasappa developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT habbanakuppedpreetham developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT gangaperiyasamy developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT santhoshlgaonkar developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT peterelobie developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT vijaypandey developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells
AT basappabasappa developmentofanenvironmentfriendlyandelectrochemicalmethodforthesynthesisofanoxadiazoledrugscaffoldthattargetspolyadpribosepolymeraseinhumanbreastcancercells